<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>AMILORIDE HYDROCHLORIDE- amiloride hydrochloride anhydrous tablet </strong><br>Carilion Materials Management<br></p></div>
<h1></h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="inv-d9833c6e-8dda-4ff9-96b2-833d13ccd6fb"></a><a name="section-1"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First"><a name="inv-56e3a600-6a64-4fd5-acf5-9ad9deceb2d7"></a>Amiloride HCl, an antikaliuretic-diuretic agent, is a pyrazine-carbonyl-guanidine that is unrelated chemically to other known antikaliuretic or diuretic agents. It is the salt of a moderately strong base (pKa 8.7). It is designated chemically as 3,5-diamino-6-chloro-N-(diaminomethylene) pyrazinecarboxamide monohydrochloride, dihydrate and has a molecular weight of 302.12. Its empirical formula is C H CIN O•HCl•2H O and its structural formula is:
                            <span class="Sub">6</span><span class="Sub">8</span><span class="Sub">7</span><span class="Sub">2</span></p>
<div class="Figure">
<a name="ID0ELGAC"></a><img alt="this is the structure." src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=875f3f5a-ed45-4646-8537-21f054302d6f&amp;name=structure.jpg">
</div>
<p><a name="inv-8d9e558d-20bd-4deb-9750-a787a4abff34"></a>Each tablet for oral administration contains 5 mg of Amiloride HCI, calculated on the anhydrous basis. Each tablet contains the following inactive ingredients: colloidal silicon dioxide, croscarmellose sodium, D&amp;C yellow #10 lake, dibasic calcium phosphate dihydrate, FD&amp;C yellow #6 lake, magnesium stearate, microcrystalline cellulose and silicon dioxide.</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="inv-46585eb1-5cff-4d0c-9b10-16a6e5e0b43f"></a><a name="section-2"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<p class="First"><a name="inv-d5743ba9-24c7-48b7-bf3c-7a695551d1f2"></a>Amiloride HCl is a potassium-conserving (antikaliuretic) drug that possesses weak (compared with thiazide diuretics) natriuretic, diuretic, and antihypertensive activity. These effects have been partially additive to the effects of thiazide diuretics in some clinical studies. When administered with a thiazide or loop diuretic, amiloride has been shown to decrease the enhanced urinary excretion of magnesium which occurs when a thiazide or loop diuretic is used alone. Amiloride has potassium-conserving activity in patients receiving kaliureticdiuretic agents.</p>
<p><a name="inv-41f73356-aa69-4dde-a948-b2528354cce6"></a>Amiloride HCl is not an aldosterone antagonist and its effects are seen even in the absence of aldosterone.</p>
<p><a name="inv-45693ee2-1163-47a1-a211-a56571adfb29"></a>Amiloride exerts its potassium sparing effect through the inhibition of sodium reabsorption at the distal convoluted tubule, cortical collecting tubule and collecting duct; this decreases the net negative potential of the tubular lumen and reduces both potassium and hydrogen secretion and their subsequent excretion. This mechanism accounts in large part for the potassium sparing action of amiloride.</p>
<p><a name="inv-ff513969-add4-47e3-a81f-73360573d861"></a>Amiloride usually begins to act within 2 hours after an oral dose. Its effect on electrolyte excretion reaches a peak between 6 and 10 hours and lasts about 24 hours. Peak plasma levels are obtained in 3 to 4 hours and the plasma half-life varies from 6 to 9 hours. Effects on electrolytes increase with single doses of amiloride HCl up to approximately 15 mg.</p>
<p><a name="inv-46dfc06c-25ac-47ac-9c82-089bba4fde65"></a>Amiloride HCl is not metabolized by the liver but is excreted unchanged by the kidneys. About 50 percent of a 20 mg dose of amiloride HCl is excreted in the urine and 40 percent in the stool within 72 hours. Amiloride has little effect on glomerular filtration rate or renal blood flow. Because amiloride HCl is not metabolized by the liver, drug accumulation is not anticipated in patients with hepatic dysfunction, but accumulation can occur if the <span class="product-label-link" type="condition" conceptid="196455" conceptname="Hepatorenal syndrome">hepatorenal syndrome</span> develops.</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="inv-1937c75c-6c71-497d-b8e4-b597b6c26880"></a><a name="section-3"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First"><a name="inv-5c39046e-5bb5-4581-97ba-ca6737d57c82"></a>Amiloride HCl is indicated as adjunctive treatment with thiazide diuretics or other kaliureticdiuretic agents in <span class="product-label-link" type="condition" conceptid="319835" conceptname="Congestive heart failure">congestive heart failure</span> or <span class="product-label-link" type="condition" conceptid="316866" conceptname="Hypertensive disorder">hypertension</span> to:</p>
<ol class="LittleAlpha">
<li>help restore normal serum potassium levels in patients who develop <span class="product-label-link" type="condition" conceptid="437833" conceptname="Hypokalemia">hypokalemia</span> on the kaliuretic diuretic.</li>
<li>prevent development of <span class="product-label-link" type="condition" conceptid="437833" conceptname="Hypokalemia">hypokalemia</span> in patients who would be exposed to particular risk if <span class="product-label-link" type="condition" conceptid="437833" conceptname="Hypokalemia">hypokalemia</span> were to develop, e.g., digitalized patients or patients with significant <span class="product-label-link" type="condition" conceptid="44784217" conceptname="Cardiac arrhythmia">cardiac arrhythmias</span>.</li>
</ol>
<p><a name="inv-92d4a8d0-1ece-4d08-9670-78ada55ddd94"></a>The use of potassium-conserving agents is often unnecessary in patients receiving diuretics for uncomplicated <span class="product-label-link" type="condition" conceptid="320128" conceptname="Essential hypertension">essential hypertension</span> when such patients have a normal diet. Amiloride HCl has little additive diuretic or antihypertensive effect when added to a thiazide diuretic.</p>
<p><a name="inv-eaac9f83-8b39-424b-9c2d-a7991a44d88e"></a>Amiloride HCl should rarely be used alone. It has weak (compared with thiazides) diuretic and antihypertensive effects. Used as single agents, potassium sparing diuretics, including amiloride HCl, result in an increased risk of <span class="product-label-link" type="condition" conceptid="434610" conceptname="Hyperkalemia">hyperkalemia</span> (approximately 10% with amiloride). Amiloride HCl should be used alone only when persistent <span class="product-label-link" type="condition" conceptid="437833" conceptname="Hypokalemia">hypokalemia</span> has been documented and only with careful titration of the dose and close monitoring of serum electrolytes.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="inv-bf6b36ae-595c-4e49-8578-251ecd827573"></a><a name="section-4"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First"><a name="inv-fc51c319-36ac-4651-bca1-70cf1eb4af8f"></a><span class="Italics"><span class="product-label-link" type="condition" conceptid="434610" conceptname="Hyperkalemia">Hyperkalemia</span></span></p>
<p><a name="inv-5407a8f1-aaf6-4653-a5c3-fe9d522d3c95"></a>Amiloride HCl should not be used in the presence of elevated serum potassium levels (greater than 5.5 mEq per liter).</p>
<p><a name="inv-2913c6dd-64aa-43ae-94bd-3fb9cfbf32c2"></a><span class="Italics">Antikaliuretic Therapy or Potassium Supplementation</span></p>
<p><a name="inv-0b783790-54dc-4c75-8827-ac1d9fa5b261"></a>Amiloride HCl should not be given to patients receiving other potassium-conserving agents, such as spironolactone or triamterene. Potassium supplementation in the form of medication, potassium-containing salt substitutes or a potassium-rich diet should not be used with amiloride HCl except in severe and/or refractory cases of <span class="product-label-link" type="condition" conceptid="437833" conceptname="Hypokalemia">hypokalemia</span>. Such concomitant therapy can be associated with rapid increases in serum potassium levels. If potassium supplementation is used, careful monitoring of the serum potassium level is necessary.</p>
<p><a name="inv-93e50ee9-87d0-4942-986d-59a91d072c9a"></a><span class="Italics"><span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">Impaired Renal Function</span></span></p>
<p><a name="inv-b51c2c14-985a-40bc-8a3a-183aeae4dad9"></a><span class="product-label-link" type="condition" conceptid="4090272" conceptname="Anuria">Anuria</span>, acute or <span class="product-label-link" type="condition" conceptid="198185" conceptname="Chronic renal failure">chronic renal insufficiency</span>, and evidence of <span class="product-label-link" type="condition" conceptid="192279" conceptname="Diabetic renal disease">diabetic nephropathy</span> are contraindications to the use of amiloride HCl. Patients with evidence of renal functional impairment (blood urea nitrogen [BUN] levels over 30 mg per 100 mL or serum creatinine levels over 1.5 mg per 100 mL) or <span class="product-label-link" type="condition" conceptid="201820" conceptname="Diabetes mellitus">diabetes</span> mellitus should not receive the drug without careful, frequent and continuing monitoring of serum electrolytes, creatinine, and BUN levels. Potassium retention associated with the use of an antikaliuretic agent is accentuated in the presence of <span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">renal impairment</span> and may result in the rapid development of <span class="product-label-link" type="condition" conceptid="434610" conceptname="Hyperkalemia">hyperkalemia</span>.</p>
<p><a name="inv-1035f3d0-5016-4a6f-9fde-5167ca5b2694"></a><span class="Italics"><span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">Hypersensitivity</span></span></p>
<p><a name="inv-0703f695-b1c0-41d5-9aaf-7230ecea9f0f"></a>Amiloride HCl is contraindicated in patients who are hypersensitive to this product.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="inv-fa769e41-5487-4f97-9dfb-f308c369b3f4"></a><a name="section-5"></a><p></p>
<h1>WARNINGS</h1>
<div class="Section" data-sectionCode="42229-5">
<a name="inv-f350d896-7d86-4d35-a4b8-d7d78e41b3e5"></a><a name="section-5.1"></a><p></p>
<h2><span class="Italics"><span class="product-label-link" type="condition" conceptid="434610" conceptname="Hyperkalemia">Hyperkalemia</span></span></h2>
<p class="First"><a name="inv-8fe55823-4e09-4339-a0f0-ce648eca12c9"></a>Like other potassium-conserving agents, amiloride may cause <span class="product-label-link" type="condition" conceptid="434610" conceptname="Hyperkalemia">hyperkalemia</span> (serum potassium levels greater than 5.5 mEq per liter) which, if uncorrected, is potentially fatal. <span class="product-label-link" type="condition" conceptid="434610" conceptname="Hyperkalemia">Hyperkalemia</span> occurs commonly (about 10%) when amiloride is used without a kaliuretic diuretic. This incidence is greater in patients with <span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">renal impairment</span>, <span class="product-label-link" type="condition" conceptid="201820" conceptname="Diabetes mellitus">diabetes</span> mellitus (with or without recognized <span class="product-label-link" type="condition" conceptid="192359" conceptname="Renal failure syndrome">renal insufficiency</span>), and in the elderly. When amiloride is used concomitantly with a thiazide diuretic in patients without these complications, the risk of <span class="product-label-link" type="condition" conceptid="434610" conceptname="Hyperkalemia">hyperkalemia</span> is reduced to about 1-2%. It is thus essential to monitor serum potassium levels carefully in any patient receiving amiloride, particularly when it is first introduced, at the time of diuretic dosage adjustments, and during any illness that could affect renal function.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="inv-224a2cb5-2ecf-46c3-98f6-6ce3d8d8acca"></a><a name="section-5.2"></a><p></p>
<h2></h2>
<p class="First"><a name="inv-7663ea18-6b6b-466d-9f5f-c2140b67ea9d"></a>The risk of <span class="product-label-link" type="condition" conceptid="434610" conceptname="Hyperkalemia">hyperkalemia</span> may be increased when potassium-conserving agents, including amiloride HCl, are administered concomitantly with an angiotensin-converting enzyme inhibitor, an angiotensin II receptor antagonist, cyclosporine or tacrolimus. (See , ) Warning signs or symptoms of <span class="product-label-link" type="condition" conceptid="434610" conceptname="Hyperkalemia">hyperkalemia</span> include <span class="product-label-link" type="condition" conceptid="4193492" conceptname="Acroparesthesia">paresthesias</span>, <span class="product-label-link" type="condition" conceptid="79908" conceptname="Muscle weakness">muscular weakness</span>, <span class="product-label-link" type="condition" conceptid="4223659" conceptname="Fatigue">fatigue</span>, <span class="product-label-link" type="condition" conceptid="4193951" conceptname="Flaccid paralysis">flaccid paralysis</span> of the extremities, <span class="product-label-link" type="condition" conceptid="4169095" conceptname="Bradycardia">bradycardia</span>, <span class="product-label-link" type="condition" conceptid="201965" conceptname="Shock">shock</span>, and ECG abnormalities. Monitoring of the serum potassium level is essential because mild <span class="product-label-link" type="condition" conceptid="434610" conceptname="Hyperkalemia">hyperkalemia</span> is not usually associated with an <span class="product-label-link" type="condition" conceptid="320536" conceptname="Electrocardiogram abnormal">abnormal ECG</span>.
                                    <span class="Bold">PRECAUTIONS</span><span class="Italics">Drug Interactions.</span></p>
<p><a name="inv-9a61a91a-6cec-4776-baf2-3e08e4541be0"></a>When abnormal, the ECG in <span class="product-label-link" type="condition" conceptid="434610" conceptname="Hyperkalemia">hyperkalemia</span> is characterized primarily by tall, peaked T waves or elevations from previous tracings. There may also be lowering of the R wave and increased depth of the S wave, widening and even disappearance of the P wave, progressive widening of the <span class="product-label-link" type="condition" conceptid="4064625" conceptname="QRS complex feature">QRS complex</span>, prolongation of the PR interval, and ST <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span>.</p>
<p><a name="inv-b00af454-7abf-4b53-917f-3b786c608164"></a>If <span class="product-label-link" type="condition" conceptid="434610" conceptname="Hyperkalemia">hyperkalemia</span> occurs in patients taking amiloride HCl, the drug should be discontinued immediately. If the serum potassium level exceeds 6.5 mEq per liter, active measures should be taken to reduce it. Such measures include the intravenous administration of sodium <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">bicarbonate</span> solution or oral or parenteral glucose with a rapid-acting insulin preparation. If needed, a cation exchange resin such as sodium polystyrene sulfonate may be given orally or by enema. Patients with persistent <span class="product-label-link" type="condition" conceptid="434610" conceptname="Hyperkalemia">hyperkalemia</span> may require dialysis.
                                    <span class="Italics">Treatment of <span class="product-label-link" type="condition" conceptid="434610" conceptname="Hyperkalemia">hyperkalemia</span>:</span></p>
<p><a name="inv-d80ea970-61fb-4785-bd2a-420384ad96c9"></a><span class="Italics"><span class="product-label-link" type="condition" conceptid="201820" conceptname="Diabetes mellitus">Diabetes</span> Mellitus</span></p>
<p><a name="inv-64d33392-340a-42ba-9399-4334604dafb1"></a>In diabetic patients, <span class="product-label-link" type="condition" conceptid="434610" conceptname="Hyperkalemia">hyperkalemia</span> has been reported with the use of all potassium-conserving diuretics, including amiloride HCl, even in patients without evidence of <span class="product-label-link" type="condition" conceptid="192279" conceptname="Diabetic renal disease">diabetic nephropathy</span>. Therefore, amiloride HCl should be avoided, if possible, in diabetic patients and, if it is used, serum electrolytes and renal function must be monitored frequently.</p>
<p><a name="inv-2dfa35c8-9e3f-4c03-a5cd-d616e77503c5"></a>Amiloride HCl should be discontinued at least 3 days before glucose tolerance testing.</p>
<p><a name="inv-c376341b-b62c-4f22-ae5d-7356083b3e0e"></a><span class="Italics">Metabolic or <span class="product-label-link" type="condition" conceptid="4048509" conceptname="Respiratory acidosis">Respiratory Acidosis</span></span></p>
<p><a name="inv-2a8d5edb-2717-498e-bafa-ec4b9cc764ce"></a>Antikaliuretic therapy should be instituted only with caution in severely ill patients in whom respiratory or <span class="product-label-link" type="condition" conceptid="4245042" conceptname="Metabolic acidosis">metabolic acidosis</span> may occur, such as patients with cardiopulmonary disease or poorly controlled <span class="product-label-link" type="condition" conceptid="201820" conceptname="Diabetes mellitus">diabetes</span>. If amiloride HCl is given to these patients, frequent monitoring of acid-base balance is necessary. Shifts in acid-base balance alter the ratio of extracellular/intracellular potassium, and the development of <span class="product-label-link" type="condition" conceptid="435517" conceptname="Acidosis">acidosis</span> may be associated with rapid increases in serum potassium levels.</p>
</div>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="inv-05e2551a-ab87-4eac-9c21-cfcaad7b43b8"></a><a name="section-6"></a><p></p>
<h1>GENERAL PRECAUTIONS</h1>
<p class="First"><a name="inv-1f92d965-a43c-4f17-870f-7bd6b07ec85e"></a><span class="Italics"><span class="product-label-link" type="condition" conceptid="4022093" conceptname="Electrolyte imbalance">Electrolyte Imbalance</span> and BUN Increases</span></p>
<p><a name="inv-5afb777b-cc09-4885-b8fb-e05542876d19"></a><span class="product-label-link" type="condition" conceptid="4232311" conceptname="Hyponatremia">Hyponatremia</span> and <span class="product-label-link" type="condition" conceptid="4016089" conceptname="Hypochloremia">hypochloremia</span> may occur when amiloride HCl is used with other diuretics and increases in BUN levels have been reported. These increases usually have accompanied vigorous fluid elimination, especially when diuretic therapy was used in seriously ill patients, such as those who had <span class="product-label-link" type="condition" conceptid="4064161" conceptname="Cirrhosis of liver">hepatic cirrhosis</span> with <span class="product-label-link" type="condition" conceptid="200528" conceptname="Ascites">ascites</span> and <span class="product-label-link" type="condition" conceptid="4030381" conceptname="Metabolic alkalosis">metabolic alkalosis</span>, or those with resistant <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">edema</span>. Therefore, when amiloride HCl is given with other diuretics to such patients, careful monitoring of serum electrolytes and BUN levels is important. In patients with pre-existing severe liver disease, <span class="product-label-link" type="condition" conceptid="4029488" conceptname="Hepatic encephalopathy">hepatic encephalopathy</span>, manifested by <span class="product-label-link" type="condition" conceptid="443782" conceptname="Tremor">tremors</span>, <span class="product-label-link" type="condition" conceptid="381273" conceptname="Confusional state">confusion</span>, and <span class="product-label-link" type="condition" conceptid="380834" conceptname="Coma">coma</span>, and increased <span class="product-label-link" type="condition" conceptid="137977" conceptname="Jaundice">jaundice</span>, have been reported in association with diuretics, including amiloride HCl.</p>
<div class="Section" data-sectionCode="34073-7">
<a name="inv-2792e3ca-0a3b-4b7c-8b0d-662a869bc948"></a><a name="section-6.1"></a><p></p>
<h2>Drug Interactions</h2>
<p class="First"><a name="inv-ec2aae23-63e7-4b5f-9db9-5574ef898e47"></a>When amiloride HCl is administered concomitantly with an angiotensin-converting enzyme inhibitor, an angiotensin II receptor antagonist, cyclosporine or tacrolimus, the risk of <span class="product-label-link" type="condition" conceptid="434610" conceptname="Hyperkalemia">hyperkalemia</span> may be increased. Therefore, if concomitant use of these agents is indicated because of demonstrated <span class="product-label-link" type="condition" conceptid="437833" conceptname="Hypokalemia">hypokalemia</span>, they should be used with caution and with frequent monitoring of serum potassium. (See ).
                                    <span class="Bold">WARNINGS</span></p>
<p><a name="inv-72085e03-7016-47a9-8d14-41bf3616d2a4"></a>Lithium generally should not be given with diuretics because they reduce its renal clearance and add a high risk of <span class="product-label-link" type="condition" conceptid="433667" conceptname="Poisoning by tetanus vaccine">lithium toxicity</span>. Read circulars for lithium preparations before use of such concomitant therapy.</p>
<p><a name="inv-a8043727-6e57-465d-989e-df7a7aeb4434"></a>In some patients, the administration of a non-steroidal anti-inflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. Therefore, when amiloride HCl and non-steroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained. Since indomethacin and potassium-sparing diuretics, including amiloride HCl, may each be associated with increased serum potassium levels, the potential effects on potassium kinetics and renal function should be considered when these agents are administered concurrently.</p>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="inv-28a44f75-6d10-4987-8fb2-252762d22447"></a><a name="section-6.2"></a><p></p>
<h2>Carcinogenesis and Mutagenesis and Impairment of Fertility</h2>
<p class="First"><a name="inv-dddc898c-400f-4e27-a7bf-5851bc15b305"></a>There was no evidence of a tumorigenic effect when amiloride HCl was administered for 92 weeks to mice at doses up to 10 mg/kg/day (25 times the maximum daily human dose). Amiloride HCl has also been administered for 104 weeks to male and female rats at doses up to 6 and 8 mg/kg/day (15 and 20 times the maximum daily dose for humans, respectively) and showed no evidence of carcinogenicity.</p>
<p><a name="inv-6f176a18-60cf-4717-ab09-76ad1b3b0d0b"></a>Amiloride HCl was devoid of mutagenic activity in various <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strains</span> of <span class="product-label-link" type="condition" conceptid="4235289" conceptname="Salmonellosis">Salmonella</span> typhimurium with or without a mammalian liver microsomal activation system (Ames test).</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="inv-0a4a8f6f-2aaf-4a18-b3d8-e2b91b93ddff"></a><a name="section-6.3"></a><p></p>
<h2>Pregnancy</h2>
<p class="First"><a name="inv-4e78eec3-3733-476f-a404-cd3369ec9b5d"></a>. <span class="product-label-link" type="condition" conceptid="4240324" conceptname="Teratogenesis">Teratogenicity</span> studies with amiloride HCl in rabbits and mice given 20 and 25 times the maximum human dose, respectively, revealed no evidence of harm to the fetus, although studies showed that the drug crossed the placenta in modest amounts. Reproduction studies in rats at 20 times the expected maximum daily dose for humans showed no evidence of impaired fertility. At approximately 5 or more times the expected maximum daily dose for humans, some toxicity was seen in adult rats and rabbits and a decrease in rat pup growth and survival occurred.
                                    <span class="Italics">Pregnancy Category B</span></p>
<p><a name="inv-a17cb712-bcd4-473e-b90b-626a958e4eb1"></a>There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.</p>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="inv-faa21399-2b67-436d-bffd-cbe86f816e5b"></a><a name="section-6.4"></a><p></p>
<h2>Nursing Mothers</h2>
<p class="First"><a name="inv-c6883f80-dd4a-4132-a800-44c6b1cb9e6c"></a>Studies in rats have shown that amiloride is excreted in milk in concentrations higher than those found in blood, but it is not known whether amiloride is excreted in human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from amiloride HCl, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="inv-c58c52e3-ef9a-427a-bbc4-49365629014a"></a><a name="section-6.5"></a><p></p>
<h2>Pediatric Use</h2>
<p class="First"><a name="inv-db7a8c32-c814-4bb4-936d-f8d54187e32b"></a>Safety and effectiveness in pediatric patients have not been established.</p>
</div>
<div class="Section" data-sectionCode="34082-8">
<a name="inv-92a03626-e2af-4d09-934c-53573a7a0fca"></a><a name="section-6.6"></a><p></p>
<h2>Geriatric Use</h2>
<p class="First"><a name="inv-902f532c-23e6-4f68-999d-95162146a449"></a>Clinical studies of amiloride HCI did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger patients. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal or cardiac function, and of concomitant disease or other drug therapy.</p>
<p><a name="inv-dbfb7e6a-cc66-4568-b450-dbb81c5e21b3"></a>This drug is known to be substantially excreted by the kidney, and the risk of toxic reactions to this drug may be greater in patients with <span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">impaired renal function</span>. Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function. (See , )
                                    <span class="Bold">CONTRAINDICATIONS</span><span class="Italics"><span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">Impaired Renal Function</span>.</span></p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="inv-bc5c5595-ed22-4cee-b0c3-ca600eaa8d8e"></a><a name="section-7"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First"><a name="inv-2a96424a-7a4a-494d-8a9e-6368cad7e84c"></a>Amiloride HCl is usually well tolerated and, except for <span class="product-label-link" type="condition" conceptid="434610" conceptname="Hyperkalemia">hyperkalemia</span> (serum potassium levels greater than 5.5 mEq liter - see WARNINGS), significant adverse effects have been reported infrequently. Minor adverse reactions were reported relatively frequently (about 20%) but the relationship of many of the reports to amiloride HCl is uncertain and the overall frequency was similar in hydrochlorothiazide treated groups. <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">Nausea</span>/<span class="product-label-link" type="condition" conceptid="442165" conceptname="Loss of appetite">anorexia</span>, <span class="product-label-link" type="condition" conceptid="200219" conceptname="Abdominal pain">abdominal pain</span>, <span class="product-label-link" type="condition" conceptid="4012503" conceptname="Excessive upper gastrointestinal gas">flatulence</span>, and mild <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">skin rash</span> have been reported and probably are related to amiloride. Other adverse experiences that have been reported with amiloride are generally those known to be associated with <span class="product-label-link" type="condition" conceptid="79936" conceptname="Polyuria">diuresis</span>, or with the underlying disease being treated.</p>
<p><a name="inv-72dcc94c-255e-461c-b3f4-fed9e28ce4b3"></a> </p>
<p><a name="inv-5b1a17b1-57df-4ab1-969b-43fd0570a070"></a>The adverse reactions for amiloride HCl listed in the following table have been arranged into two groups: (1) incidence greater than one percent; and (2) incidence one percent or less. The incidence for group (1) was determined from clinical studies conducted in the United States (837 patients treated with amiloride HCl). The adverse effects listed in group (2) include reports from the same clinical studies and voluntary reports since marketing. The probability of a causal relationship exists between amiloride HCl and these adverse reactions, some of which have been reported only rarely.</p>
<a name="inv-4b0a5a0d-8b34-41c9-bef6-a599f8d9587f"></a><table border="1" frame="border">
<col width="316px">
<col width="316px">
<tfoot><tr class="First Last"><td colspan="2">
<p class="First Footnote"><a name="inv-af29fe81-fd60-40e9-8031-952b6da42146"></a>*Reactions occurring in 3% to 8% of patients treated with amiloride HCl.</p>
<p class="Footnote"><a name="inv-3c3677aa-238a-4724-aa25-69ec522e0709"></a>(Those reactions occurring in less than 3% of the patients are unmarked.)</p>
<p class="Footnote"><a name="inv-d3f0373a-add5-4e2e-ae69-5a6046a19a22"></a>**See WARNINGS.</p>
</td></tr></tfoot>
<tbody class="Headless">
<tr class="First">
<td class="Botrule Lrule Rrule" valign="middle"><span class="Bold">Incidence &gt; 1%</span></td>
<td class="Botrule Rrule" valign="middle"><span class="Bold">Incidence ≤ 1%</span></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="middle"><span class="Bold"><span class="Italics"><span class="Italics"><span class="Italics"><span class="Italics"><span class="Italics">Body as a Whole</span></span></span></span></span></span></td>
<td class="Botrule Rrule" valign="middle"> </td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">Headache</span>*</td>
<td class="Botrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="134736" conceptname="Backache">Back pain</span></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="437113" conceptname="Asthenia">Weakness</span></td>
<td class="Botrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="77670" conceptname="Chest pain">Chest pain</span></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="4223659" conceptname="Fatigue">Fatigability</span></td>
<td class="Botrule Rrule" valign="middle">Neck/shoulder <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">ache</span></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="middle"><span class="Bold"><span class="Italics"><span class="Italics"><span class="Italics"><span class="Italics"><span class="Italics"> </span></span></span></span></span></span></td>
<td class="Botrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">Pain</span>, extremities</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="middle"><span class="Bold"><span class="Italics"><span class="Italics"><span class="Italics"><span class="Italics"><span class="Italics">Cardiovascular</span></span></span></span></span></span></td>
<td class="Botrule Rrule" valign="middle"> </td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="middle">None</td>
<td class="Botrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="321318" conceptname="Angina pectoris">Angina pectoris</span></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" rowspan="2" valign="middle"><span class="Bold"><span class="Italics"><span class="Italics"><span class="Italics"><span class="Italics"><span class="Italics"> </span></span></span></span></span></span></td>
<td class="Botrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="319041" conceptname="Orthostatic hypotension">Orthostatic hypotension</span></td>
</tr>
<tr><td class="Botrule Lrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="44784217" conceptname="Cardiac arrhythmia">Arrhythmia</span></td></tr>
<tr>
<td class="Botrule Lrule Rrule" valign="middle"><span class="Bold"><span class="Italics"><span class="Italics"><span class="Italics"><span class="Italics"><span class="Italics"> </span></span></span></span></span></span></td>
<td class="Botrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="315078" conceptname="Palpitations">Palpitation</span></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="middle"><span class="Bold"><span class="Italics"><span class="Italics"><span class="Italics"><span class="Italics"><span class="Italics">Digestive</span></span></span></span></span></span></td>
<td class="Botrule Rrule" valign="middle"> </td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">Nausea</span>/<span class="product-label-link" type="condition" conceptid="442165" conceptname="Loss of appetite">anorexia</span>*</td>
<td class="Botrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="137977" conceptname="Jaundice">Jaundice</span></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">Diarrhea</span>*</td>
<td class="Botrule Rrule" valign="middle">GI <span class="product-label-link" type="condition" conceptid="437312" conceptname="Bleeding">bleeding</span></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">Vomiting</span>*</td>
<td class="Botrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="4218984" conceptname="Abdominal distension">Abdominal fullness</span></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="200219" conceptname="Abdominal pain">Abdominal pain</span></td>
<td class="Botrule Rrule" valign="middle">GI disturbance</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="4218984" conceptname="Abdominal distension">Gas pain</span></td>
<td class="Botrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="4241197" conceptname="Thirst">Thirst</span></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="middle">Appetite changes</td>
<td class="Botrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="23325" conceptname="Heartburn">Heartburn</span></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="75860" conceptname="Constipation">Constipation</span></td>
<td class="Botrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="4012503" conceptname="Excessive upper gastrointestinal gas">Flatulence</span></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="middle"> </td>
<td class="Botrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="23325" conceptname="Heartburn">Dyspepsia</span></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="middle">Elevated serum potassium levels 
      (&gt;5.5 mEq per liter)**
                                        <span class="Bold"><span class="Italics"><span class="Italics"><span class="Italics"><span class="Italics"><span class="Italics">Metabolic</span></span></span></span></span></span>
</td>
<td class="Botrule Rrule" valign="middle"> 
     None</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="middle"><span class="Bold"><span class="Italics"><span class="Italics"><span class="Italics"><span class="Italics"><span class="Italics">Skin</span></span></span></span></span></span></td>
<td class="Botrule Rrule" valign="middle"> </td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="middle">None</td>
<td class="Botrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">Skin rash</span></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" rowspan="4" valign="middle"> </td>
<td class="Botrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="4302654" conceptname="Itching">Itching</span></td>
</tr>
<tr><td class="Botrule Lrule Rrule" valign="middle">Dryness of mouth</td></tr>
<tr><td class="Botrule Lrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="4169287" conceptname="Itching of skin">Pruritus</span></td></tr>
<tr><td class="Botrule Lrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="133280" conceptname="Alopecia">Alopecia</span></td></tr>
<tr>
<td class="Botrule Lrule Rrule" valign="middle"><span class="Bold"><span class="Italics"><span class="Italics"><span class="Italics"><span class="Italics"><span class="Italics">Musculoskeletal</span></span></span></span></span></span></td>
<td class="Botrule Rrule" valign="middle"> </td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="75635" conceptname="Cramp">Muscle cramps</span></td>
<td class="Botrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="77074" conceptname="Joint pain">Joint pain</span></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="middle"> </td>
<td class="Botrule Rrule" valign="middle">Leg <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">ache</span></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="middle"><span class="Bold"><span class="Italics"><span class="Italics"><span class="Italics"><span class="Italics"><span class="Italics">Nervous</span></span></span></span></span></span></td>
<td class="Botrule Rrule" valign="middle"> </td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">Dizziness</span></td>
<td class="Botrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="4193492" conceptname="Acroparesthesia">Paresthesia</span></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="372887" conceptname="Disorder of brain">Encephalopathy</span></td>
<td class="Botrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="443782" conceptname="Tremor">Tremors</span></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="middle"> </td>
<td class="Botrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="439383" conceptname="Vertigo">Vertigo</span></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="middle"><span class="Bold"><span class="Italics"><span class="Italics"><span class="Italics"><span class="Italics"><span class="Italics">Psychiatric</span></span></span></span></span></span></td>
<td class="Botrule Rrule" valign="middle"> </td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="middle">None</td>
<td class="Botrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="436817" conceptname="Feeling nervous">Nervousness</span></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" rowspan="5" valign="middle"> </td>
<td class="Botrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="381273" conceptname="Confusional state">Mental confusion</span></td>
</tr>
<tr><td class="Botrule Lrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="436962" conceptname="Insomnia">Insomnia</span></td></tr>
<tr><td class="Botrule Lrule Rrule" valign="middle">Decreased libido</td></tr>
<tr><td class="Botrule Lrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">Depression</span></td></tr>
<tr><td class="Botrule Lrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">Somnolence</span></td></tr>
<tr>
<td class="Botrule Lrule Rrule" valign="middle"><span class="Bold"><span class="Italics"><span class="Italics"><span class="Italics"><span class="Italics"><span class="Italics">Respiratory</span></span></span></span></span></span></td>
<td class="Botrule Rrule" valign="middle"> </td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="254761" conceptname="Cough">Cough</span></td>
<td class="Botrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="312437" conceptname="Dyspnea">Shortness of Breath</span></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="312437" conceptname="Dyspnea">Dyspnea</span></td>
<td class="Botrule Rrule" valign="middle"> </td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="middle"><span class="Bold"><span class="Italics"><span class="Italics"><span class="Italics"><span class="Italics"><span class="Italics">Special Senses</span></span></span></span></span></span></td>
<td class="Botrule Rrule" valign="middle"> </td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="middle">None</td>
<td class="Botrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="374034" conceptname="Visual disturbance">Visual disturbances</span></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" rowspan="3" valign="middle"> </td>
<td class="Botrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="4195085" conceptname="Nasal congestion">Nasal congestion</span></td>
</tr>
<tr><td class="Botrule Lrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="377575" conceptname="Tinnitus">Tinnitus</span></td></tr>
<tr><td class="Botrule Lrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="4011560" conceptname="Raised intraocular pressure">Increased intraocular pressure</span></td></tr>
<tr>
<td class="Botrule Lrule Rrule" valign="middle"><span class="Bold"><span class="Italics"><span class="Italics"><span class="Italics"><span class="Italics"><span class="Italics">Urogenital</span></span></span></span></span></span></td>
<td class="Botrule Rrule" valign="middle"> </td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="4216771" conceptname="Impotence">Impotence</span></td>
<td class="Botrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="79936" conceptname="Polyuria">Polyuria</span></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" rowspan="4" valign="middle"> </td>
<td class="Botrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="197684" conceptname="Dysuria">Dysuria</span></td>
</tr>
<tr><td class="Botrule Lrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="4012368" conceptname="Increased frequency of urination">Urinary frequency</span></td></tr>
<tr><td class="Botrule Lrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="4090870" conceptname="Spasm of bladder">Bladder spasms</span></td></tr>
<tr class="Last"><td class="Botrule Lrule Rrule" valign="middle"><span class="product-label-link" type="condition" conceptid="4168447" conceptname="Gynecomastia">Gynecomastia</span></td></tr>
</tbody>
</table>
<p><a name="inv-b436ffad-60d9-4947-877e-619e3c011cdd"></a><span class="Italics">Causal Relationship Unknown</span></p>
<p><a name="inv-06216777-2e7a-47c9-9dc7-0f9f1579a654"></a>Other reactions have been reported but occurred under circumstances where a causal relationship could not be established. However, in these rarely reported events, that possibility cannot be excluded. Therefore, these observations are listed to serve as alerting information to physicians.</p>
<p><a name="inv-ae638532-bf76-4c28-83b7-e712d32fa7a2"></a>Activation of probable pre-existing <span class="product-label-link" type="condition" conceptid="4027663" conceptname="Peptic ulcer">peptic ulcer</span></p>
<p><a name="inv-f6cd0323-a694-427c-985c-023a4738cb3c"></a><span class="product-label-link" type="condition" conceptid="137829" conceptname="Aplastic anemia">Aplastic anemia</span></p>
<p><a name="inv-baa21ba3-0a3b-405f-ac3d-79788c4cbc75"></a><span class="product-label-link" type="condition" conceptid="320073" conceptname="Neutropenia">Neutropenia</span></p>
<p><a name="inv-0e6b7e26-f64b-468f-872f-b58cea2f748c"></a>Abnormal liver function</p>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="inv-524baec3-2674-4a9a-bf70-dc2ddea6272a"></a><a name="section-8"></a><p></p>
<h1>OVERDOSAGE</h1>
<p class="First"><a name="inv-af86efb3-6c14-48dc-8b8c-70cdb3afdc2d"></a>No data are available in regard to overdosage in humans.</p>
<p><a name="inv-d41f0628-0cb6-4731-bf18-ad8186b632af"></a>The oral LD of amiloride HCl (calculated as the base) is 56 mg/kg in mice and 36 to 85 mg/kg in rats, depending on the <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strain</span>.
                            <span class="Sub">50</span></p>
<p><a name="inv-fcd9f37f-ae58-4a22-b765-880d07a9c453"></a>It is not known whether the drug is dialyzable.</p>
<p><a name="inv-70b8f0b3-e26f-4b16-afb8-abba798116d2"></a>The most likely signs and symptoms to be expected with overdosage are <span class="product-label-link" type="condition" conceptid="435796" conceptname="Dehydration">dehydration</span> and <span class="product-label-link" type="condition" conceptid="4022093" conceptname="Electrolyte imbalance">electrolyte imbalance</span>. These can be treated by established procedures. Therapy with amiloride HCl should be discontinued and the patient observed closely. There is no specific antidote.<span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">Emesis</span> should be induced or gastric lavage performed.Treatment is symptomatic and supportive. If <span class="product-label-link" type="condition" conceptid="434610" conceptname="Hyperkalemia">hyperkalemia</span> occurs, active measures should be taken to reduce the serum potassium levels.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="inv-20099c9f-21b7-4419-9ad1-754927ee2594"></a><a name="section-9"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First"><a name="inv-344caea4-156b-41c7-89dc-92ec68235d42"></a>Amiloride HCl should be administered with food.</p>
<p><a name="inv-405575d7-709e-4644-9b24-f711c591553b"></a>Amiloride HCl, one 5 mg tablet daily, should be added to the usual antihypertensive or diuretic dosage of a kaliuretic diuretic. The dosage may be increased to 10 mg per day, if necessary. More than two 5 mg tablets of amiloride HCl daily usually are not needed, and there is little controlled experience with such doses. If persistent <span class="product-label-link" type="condition" conceptid="437833" conceptname="Hypokalemia">hypokalemia</span> is documented with 10 mg, the dose can be increased to 15 mg, then 20 mg, with careful monitoring of electrolytes.</p>
<p><a name="inv-613c49e2-a760-4ec1-8db7-6d24b6a43a8b"></a>In treating patients with <span class="product-label-link" type="condition" conceptid="319835" conceptname="Congestive heart failure">congestive heart failure</span> after an initial <span class="product-label-link" type="condition" conceptid="79936" conceptname="Polyuria">diuresis</span> has been achieved, potassium loss may also decrease and the need for amiloride HCl should be re-evaluated. Dosage adjustment may be necessary. Maintenance therapy may be on an intermittent basis.</p>
<p><a name="inv-c05b1c21-fe54-480f-92ce-7a4b6d0be4ca"></a>If it is necessary to use amiloride HCl alone (see INDICATIONS), the starting dosage should be one 5 mg tablet daily. This dosage may be increased to 10 mg per day, if necessary. More than two 5 mg tablets usually are not needed, and there is little controlled experience with such doses. If persistent <span class="product-label-link" type="condition" conceptid="437833" conceptname="Hypokalemia">hypokalemia</span> is documented with 10 mg, the dose can be increased to 15 mg, then 20 mg, with careful monitoring of electrolytes.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="inv-64d5ec20-41bf-4aff-a06d-730eed301a3b"></a><a name="section-10"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">NDC:68151-0162-0 in a PACKAGE of 1 TABLETS</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="inv-0b9b96b9-6ba0-4f0b-b625-f8ec7454b58d"></a><a name="section-11"></a><p></p>
<h1>AMILORIDE HYDROCHLORIDE TABLET</h1>
<div class="Figure"><img alt="Label Image" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=875f3f5a-ed45-4646-8537-21f054302d6f&amp;name=68151-0162.jpg"></div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>AMILORIDE HYDROCHLORIDE 		
					</strong><br><span class="contentTableReg">amiloride hydrochloride tablet</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:68151-0162(NDC:49884-117)</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>AMILORIDE HYDROCHLORIDE ANHYDROUS</strong> (AMILORIDE) </td>
<td class="formItem">AMILORIDE HYDROCHLORIDE ANHYDROUS</td>
<td class="formItem">5 mg</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>D&amp;C YELLOW NO. 10</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>FD&amp;C YELLOW NO. 6</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>MAGNESIUM STEARATE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>CELLULOSE, MICROCRYSTALLINE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>SILICON DIOXIDE</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">YELLOW</td>
<td class="formLabel">Score</td>
<td class="formItem">no score</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem">ROUND</td>
<td class="formLabel">Size</td>
<td class="formItem">7mm</td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem"></td>
<td class="formLabel">Imprint Code</td>
<td class="formItem">Par;117</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">    </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:68151-0162-0</td>
<td class="formItem">1  in 1 PACKAGE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA070346</td>
<td class="formItem">01/22/1986</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Carilion Materials Management
							(079239644)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Registrant - </span>Carilion Materials Management (079239644)</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Carilion Materials Management</td>
<td class="formItem"></td>
<td class="formItem">079239644</td>
<td class="formItem">REPACK(68151-0162)</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 2/2012<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>360aba5b-d3e9-4ec0-8eaa-b391651f45c5</div>
<div>Set id: 875f3f5a-ed45-4646-8537-21f054302d6f</div>
<div>Version: 2</div>
<div>Effective Time: 20120215</div>
</div>
</div> <div class="DistributorName">Carilion Materials Management</div></p>
</body></html>
